Free Trial

Neumora Therapeutics (NMRA) Insider Trading & Ownership

Neumora Therapeutics logo
$9.74 +0.05 (+0.52%)
(As of 11/22/2024 ET)

Neumora Therapeutics (NASDAQ:NMRA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
26.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$1.39 M
Get NMRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neumora Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NMRA Insider Buying and Selling by Quarter

Neumora Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/18/2024Matthew K FustDirectorSell14,049$17.03$239,254.47  
10/9/2024Robert A LenzInsiderSell5,563$15.01$83,500.63  
9/17/2024Robert A LenzInsiderSell30,788$11.81$363,606.28  
8/26/2024Joshua PintoCFOSell31,642$11.78$372,742.76  
8/22/2024Joshua PintoCFOSell28,496$11.63$331,408.48  
(Data available from 1/1/2013 forward)

NMRA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Neumora Therapeutics includes Amgen Inc, Arch Venture Partners Xii, Llc, Henry O Gosebruch, Joshua Pinto, Kristina Burow, Matthew K Fust, and Robert A Lenz. Learn more on insiders at NMRA.

26.40% of Neumora Therapeutics stock is owned by insiders. Learn more on NMRA's insider holdings.

The following insiders have purchased NMRA shares in the last 24 months: Amgen Inc ($29,999,985.00), Arch Venture Partners Xii, Llc ($2,626,582.57), Henry O Gosebruch ($189,300.00), and Kristina Burow ($28,803,319.17).

Insiders have purchased a total of 3,786,769 NMRA shares in the last 24 months for a total of $61,619,186.74 bought.

The following insiders have sold NMRA shares in the last 24 months: Joshua Pinto ($704,151.24), Matthew K Fust ($239,254.47), and Robert A Lenz ($447,106.91).

Insiders have sold a total of 110,538 Neumora Therapeutics shares in the last 24 months for a total of $1,390,512.62 sold.

Neumora Therapeutics Key Executives

  • Mr. Paul L. Berns (Age 57)
    Co-Founder & Executive Chairman
    Compensation: $1.65M
  • Mr. Henry O. Gosebruch (Age 51)
    President, CEO & Director
    Compensation: $3.33M
  • Mr. Jason G. Duncan (Age 50)
    Chief Legal Officer
    Compensation: $315k
  • Mr. Robert Lenz M.D. (Age 53)
    Ph.D., Head of Research & Development
    Compensation: $770.29k
  • Ms. Carol Suh (Age 34)
    Co-Founder & COO
  • Dr. Robert Michael Poole FACP (Age 67)
    M.D., Co-Founder & Advisor
  • Dr. Joshua Pinto Ph.D. (Age 39)
    Chief Financial Officer
    Compensation: $876.64k
  • Mr. Michael Lee Milligan
    Principal Accounting Officer
  • Dr. Rajesh Manchanda Ph.D. (Age 58)
    Chief Technical Operations Officer
  • Mr. Nicholas Brandon Ph.D. (Age 50)
    Chief Scientific Officer


This page (NASDAQ:NMRA) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners